Shopping Cart
- Remove All
Your shopping cart is currently empty
Antalarmin is a selective and potent corticotropin-releasing factor receptor 1 (CRHR1) antagonist that crosses the blood-brain barrier and blocks CRF activation and carrageenan-induced subcutaneous inflammation in rats.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $454 | 1-2 weeks | |
| 50 mg | $614 | 1-2 weeks | |
| 100 mg | $828 | 1-2 weeks |
| Description | Antalarmin is a selective and potent corticotropin-releasing factor receptor 1 (CRHR1) antagonist that crosses the blood-brain barrier and blocks CRF activation and carrageenan-induced subcutaneous inflammation in rats. |
| Targets&IC50 | CRHR1:2.7 nM (Ki) |
| In vitro | Antalarmin (100 nM; 48 hours) treatment was able to block CRF-induced increases in PKAIIβ levels in hippocampal neurons derived from Tg2576 mice[2]. |
| In vivo | In the chronic mild stress model using BALB/cByJIco male mice, intraperitoneal administration of Antalarmin (10 mg/kg; once daily for 4 weeks) was able to significantly improve the physical state of the mice[1]. |
| Molecular Weight | 378.55 |
| Formula | C24H34N4 |
| Cas No. | 157284-96-3 |
| Smiles | N=1C(=NC(=C2C1N(C=3C(=CC(=CC3C)C)C)C(=C2C)C)N(CC)CCCC)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 20 mg/mL (52.83 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.